MENU
+Compare
DYAI
Stock ticker: NASDAQ
AS OF
Dec 4, 04:59 PM (EDT)
Price
$1.00
Change
+$0.06 (+6.38%)
Capitalization
34.1M

DYAI Dyadic International Forecast, Technical & Fundamental Analysis

Dyadic International Inc is a worldwide biotechnology platform company... Show more

Industry: #Biotechnology
DYAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DYAI with price predictions
Dec 03, 2025

DYAI in downward trend: 10-day moving average broke below 50-day moving average on November 10, 2025

The 10-day moving average for DYAI crossed bearishly below the 50-day moving average on November 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

DYAI moved below its 50-day moving average on November 04, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DYAI entered a downward trend on December 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on DYAI as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DYAI just turned positive on November 26, 2025. Looking at past instances where DYAI's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DYAI advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

DYAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DYAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.072) is normal, around the industry mean (27.112). P/E Ratio (0.000) is within average values for comparable stocks, (52.721). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.882). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (17.182) is also within normal values, averaging (324.716).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
DYAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DYAI is expected to report earnings to fall 35.00% to -3 cents per share on March 31

Dyadic International DYAI Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Missed
by $0.01
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Est.
$-0.07
The last earnings report on November 12 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 186.77K shares outstanding, the current market capitalization sits at 34.10M.
A.I. Advisor
published General Information

General Information

a researcher and manufacturer of genes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1044 North U.S. Highway One
Phone
+1 561 743-8333
Employees
7
Web
https://www.dyadic.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAUT2.080.10
+5.05%
Nautilus Biotechnolgy
DE481.8212.67
+2.70%
Deere & Company
FGEN8.120.04
+0.50%
FibroGen Inc
HXL75.380.07
+0.09%
Hexcel Corp
PRA23.93N/A
N/A
ProAssurance Corp

DYAI and Stocks

Correlation & Price change

A.I.dvisor tells us that DYAI and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DYAI and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYAI
1D Price
Change %
DYAI100%
+4.09%
VRAX - DYAI
31%
Poorly correlated
+75.11%
MDGL - DYAI
29%
Poorly correlated
+1.18%
FATE - DYAI
28%
Poorly correlated
+7.46%
TAOX - DYAI
27%
Poorly correlated
+7.70%
QSI - DYAI
25%
Poorly correlated
+7.09%
More